Skip to main content
Medicine logoLink to Medicine
. 2017 Sep 29;96(39):e8225. doi: 10.1097/MD.0000000000008225

Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review: Erratum

PMCID: PMC5626331  PMID: 31305716

In the article, “Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review”,[1] which appeared in Volume 96, Issue 36 of Medicine, the arrows in panels C and D of Figure 1 were incorrectly placed. The corrected figure is below.

Figure 1.

Figure 1

Preoperative MRI characteristics of the pituitary lesion: (A) coronal T1WI, (B) coronal T2WI, (C) coronal-enhanced T1WI, (D) sagittal-enhanced T1WI). MRI = magnetic resonance imaging, T1WI = T1-weighted image, T2WI = T2-weighted image.

Reference

  • [1].Yang C, Wu H, Wang J. Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review. Medicine. 2017. 96:e8017. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES